Skip to main content
Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
Published Web Location
http://europepmc.org/articles/PMC4721063?pdf=renderNo data is associated with this publication.
Abstract
© 2016 Anwar et al. Background and purpose: Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in delive
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.